O'Shares Investment Advisers’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-97,874
Closed -$7.42M 46
2022
Q1
$7.42M Buy
97,874
+5,464
+6% +$433K 0.59% 38
2021
Q4
$7.89M Buy
92,410
+6,715
+8% +$524K 0.56% 41
2021
Q3
$6.48M Buy
85,695
+6,562
+8% +$521K 0.48% 64
2021
Q2
$6.44M Buy
79,133
+1,928
+2% +$158K 0.45% 72
2021
Q1
$6.09M Sell
77,205
-354
-0.5% -$27.7K 0.45% 74
2020
Q4
$6.63M Buy
77,559
+7,368
+10% +$609K 0.51% 73
2020
Q3
$5.42M Buy
70,191
+11,645
+20% +$888K 0.56% 55
2020
Q2
$4.29M Sell
58,546
-7,260
-11% -$516K 0.54% 48
2020
Q1
$4.37M Sell
65,806
-50
-0.1% -$3.53K 0.78% 34
2019
Q4
$4.53M Buy
65,856
+3,546
+6% +$242K 0.62% 37
2019
Q3
$4.58M Sell
62,310
-837
-1% -$60.7K 0.69% 36
2019
Q2
$4.53M Buy
63,147
+3,689
+6% +$262K 0.72% 33
2019
Q1
$4.08M Buy
59,458
+1,736
+3% +$112K 0.69% 33
2018
Q4
$3.44M Buy
+57,722
New +$3.61M 0.66% 35

Other funds holding CL

O'Shares Investment Advisers's CL Position: Q2 2022 in Review

O'Shares Investment Advisers sold out of Colgate-Palmolive (CL) in Q2 2022, closing a stake of 97,874 shares — an estimated $7.42M sold.

O'Shares Investment Advisers first reported a position in CL in Q4 2018 and held it in 14 quarters. The position peaked at $7.89M in Q4 2021. 1,668 funds tracked by Wall St. Rank hold CL as of Q2 2022.

  • O'Shares Investment Advisers reported no remaining Colgate-Palmolive position as of Q2 2022 after selling out during the quarter.
  • O'Shares Investment Advisers sold 97,874 Colgate-Palmolive shares in Q2 2022, an estimated $7.42M.
  • O'Shares Investment Advisers first reported a position in Colgate-Palmolive in Q4 2018 and held it in 14 quarters.
  • O'Shares Investment Advisers's Colgate-Palmolive position peaked at $7.89M in Q4 2021.
  • 1,668 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2022.

Based on O'Shares Investment Advisers's 13F filing for Q2 2022.